{"id":111153,"date":"2021-08-05T09:14:47","date_gmt":"2021-08-05T01:14:47","guid":{"rendered":"https:\/\/www.chinapulse.com\/?p=293651"},"modified":"2021-08-05T09:14:47","modified_gmt":"2021-08-05T01:14:47","slug":"china-tech-digest-sensetime-launches-ai-drug-development-byd-starts-data-cooperation-with-vastbase","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2021\/08\/05\/china-tech-digest-sensetime-launches-ai-drug-development-byd-starts-data-cooperation-with-vastbase\/","title":{"rendered":"China Tech Digest: SenseTime Launches AI Drug Development; BYD Starts Data Cooperation With Vastbase"},"content":{"rendered":"<p><img width=\"696\" height=\"429\" src=\"https:\/\/www.chinapulse.com\/wp-content\/uploads\/AInnovation.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"margin: auto;margin-bottom: 5px;max-width: 100%\" \/><\/p>\n<p>SenseTime launches AI drug development SenseTime published a number of latest research results, covering drug discovery, preclinical research, clinical trials, post-marketing of new drugs and other drug development links, aiming to accelerate new drug research and marketing process through AI technology, shorten the new drug R&#38;D cycle, and reduce drugs R&#38;D costs and increase the [\u2026]<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/www.chinamoneynetwork.com\/2021\/08\/05\/china-tech-digest-sensetime-launches-ai-drug-development-byd-starts-data-cooperation-with-vastbase\">China Tech Digest: SenseTime Launches AI Drug Development; BYD Starts Data Cooperation With Vastbase<\/a> comes from <a rel=\"nofollow\" href=\"https:\/\/www.chinamoneynetwork.com\/\">China Money Network<\/a>: Primary Data for China&#8217;s Primary Markets!&#8230;<\/p>","protected":false},"excerpt":{"rendered":"<p>SenseTime launches AI drug development SenseTime published a number of latest research results, covering drug discovery, preclinical research, clinical trials, post-marketing of new drugs and other drug development links, aiming to accelerate new drug&#8230;<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[144,213,194,1542],"tags":[1982],"class_list":["post-111153","post","type-post","status-publish","format-standard","hentry","category-china","category-china-news","category-news-chinese-law","category-technology","tag-byd"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/111153"}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=111153"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/111153\/revisions"}],"predecessor-version":[{"id":111154,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/111153\/revisions\/111154"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=111153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=111153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=111153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}